Listar por autor "Beran, David"

Ordenar por:Orden:Resultados:

  • Diagnostics and monitoring tools for noncommunicable diseases: a missing component in the global response 
    Bernabé Ortiz, Antonio; Zafra-Tanaka, Jessica Hanae; Moscoso-Porras, Miguel; Sampath, Rangarajan; Vetter, Beatrice; Miranda, J. Jaime; Beran, David (BioMed Central, 2021)
    A key component of any health system is the capacity to accurately diagnose individuals. One of the six building blocks of a health system as defined by the World Health Organization (WHO) includes diagnostic tools. The ...
  • Disruption, changes, and adaptation: Experiences with chronic conditions in Mozambique, Nepal and Peru. 
    Pesantes Villa, María Amalia; Somerville, Claire; Singh, Suman Bahadur; Pérez León Quinoso, Silvana Patricia; Madede, Tavares; Suggs, Suzanne; Beran, David (Taylor and Francis, 2019)
    Chronic conditions are an increasing problem in Low- and Middle-Income Countries (LMICs) yet, the challenges faced by low-income populations with these conditions in such countries are not well understood. Based on in-depth ...
  • Forty years since Alma-Ata: do we need a new model for noncommunicable diseases? 
    Beran, David; Perel, Pablo; Miranda, J. Jaime (International Society of Global Health, 2019)
    Last year marked the 40th Anniversary of the Alma-Ata Declaration which stated that Primary Health Care (PHC) was “essential health care based on practical, scientifically sound and socially acceptable methods and technology ...
  • A global perspective on the issue of access to insulin 
    Beran, David; Lazo Porras, María de los Ángeles; Mba, Camille M.; Mbanya, Jean Claude (Springer, 2021)
    The discovery of insulin in 1921 changed the prognosis for people with type 1 diabetes. A century later, availability and affordability of insulin remain a challenge in many parts of the globe. Using the WHO's framework ...
  • Health system responses for type 1 diabetes: A scoping review 
    Zafra-Tanaka, Jessica Hanae; Beran, David; Bernabé Ortiz, Antonio (Wiley, 2022)
    Aims: The focus of health system interventions for noncommunicable diseases and diabetes focus mainly on primary health care responses. However, existing interventions are not necessarily adapted for the complex management ...
  • Health systems research for policy change: lessons from the implementation of rapid assessment protocols for diabetes in low- and middle-income settings 
    Beran, David; Miranda, J. Jaime; Cárdenas García-Santillán, María Kathia; Bigdeli, Maryam (BioMed Central, 2015)
    BACKGROUND: As many challenges exist for access to diabetes care in developing countries, the International Insulin Foundation developed a Rapid Assessment tool and implemented this approach to identify barriers to care ...
  • High-quality health systems: time for a revolution in research and research funding 
    Beran, David; Chappuis, Francois; Damasceno, Albertino; Jha, Nilambar; Pesantes Villa, María Amalia; Singh, Suman Bahadur; Somerville, Claire; Suggs, L. Suzanne; Miranda, J. Jaime (Elsevier, 2019)
    The launch of two landmark publications on the quality of care in the world's poorest populations, including The Lancet Global Health Commission on high-quality health systems in the Sustainable Development Goals era ...
  • How to bring research evidence into policy? Synthesizing strategies of five research projects in low-and middle-income countries 
    Erismann, Séverine; Pesantes Villa, María Amalia; Beran, David; Leuenberger, Andrea; Farnham, Andrea; Berger Gonzalez de White, Monica; Labhardt, Niklaus Daniel; Tediosi, Fabrizio; Akweongo, Patricia; Kuwawenaruwa, August; Zinsstag, Jakob; Brugger, Fritz; Somerville, Claire; Wyss, Kaspar; Prytherch, Helen (BioMed Central, 2021)
    BACKGROUND: Addressing the uptake of research findings into policy-making is increasingly important for researchers who ultimately seek to contribute to improved health outcomes. The aims of the Swiss Programme for Research ...
  • Implementation of a salt substitute intervention using social marketing in resourced-limited communities in Peru: a process evaluation study 
    Lazo Porras, María de los Ángeles; Del Valle, Adela; Beran, David; Pesantes Villa, María Amalia; Pérez León Quinoso, Silvana Patricia; Ponce Lucero, Vilarmina; Bernabé Ortiz, Antonio; Cárdenas García-Santillán, María Kathia; Chappuis, François; Perel, Pablo; Miranda, J. Jaime; Diez-Canseco Montero, Francisco (Frontiers, 2023)
    Objective: This study aimed to conduct a process evaluation of a salt substitute trial conducted in Peru. Methods: Through semi-structured interviews of intervention participants, we documented and analyzed process evaluation ...
  • The Lancet Diabetes & Endocrinology Commission on type 1 diabetes: looking back to move forward. 
    Beran, David; Koch, Marta; Ajmal, Sana; de Beaufort, Carine; Ramaiya, Kaushik; Zafra-Tanaka, Jessica Hanae; Atkinson, Mark (Elsevier, 2023)
    Kofi Annan, former UN Secretary General and Nobel Prize winner, was noted for his many words of wisdom, including: “One has to learn from history. Quite frankly, it is almost impossible to have a sense of vision without a ...
  • Lessons learned about co-creation: developing a complex intervention in rural Peru 
    Lazo Porras, María de los Ángeles; Pérez León Quinoso, Silvana Patricia; Cárdenas García-Santillán, María Kathia; Pesantes Villa, María Amalia; Miranda, J. Jaime; Suggs, L. Suzanne; Chappuis, François; Perel, Pablo; Beran, David (Taylor and Francis, 2020)
    Background: Co-creation is the process of involving stakeholders in the development of interventions. Although co-creation is becoming more widespread, reports of the process and lessons learned are scarce. Objective: To ...
  • Moving from formative research to co-creation of interventions: insights from a community health system project in Mozambique, Nepal and Peru 
    Beran, David; Lazo Porras, María de los Ángeles; Cárdenas García-Santillán, María Kathia; Chappuis, Francois; Damasceno, Albertino; Jha, Nilambar; Madede, Tavares; Lachat, Sarah; Pérez León Quinoso, Silvana Patricia; Aya Pastrana, Nathaly; Pesantes Villa, María Amalia; Singh, Suman Bahadur; Sharma, Sanjib; Somerville, Claire; Suggs, L. Suzanne; Miranda, J. Jaime (BMJ Publishing Group, 2018)
    Different methodological approaches for implementation research in global health focusing on how interventions are developed, implemented and evaluated are needed. In this paper, we detail the approach developed and ...
  • The need to focus on primary health care for chronic diseases 
    Beran, David; Chappuis, Francois; Cattacin, Sandro; Damasceno, Albertino; Jha, Nilambar; Somerville, Claire; Suggs, L. Suzanne; Miranda, J. Jaime (Elsevier, 2016)
    In The Lancet Diabetes & Endocrinology, a recent Editorial1 and a Review by Eric Nou and colleagues2 about the link between HIV/AIDS and cardiovascular disease address the double burden of communicable diseases and ...
  • Outcomes measured in studies assessing health systems interventions for type 1 diabetes management: A scoping review. 
    Zafra-Tanaka, Jessica Hanae; Del Valle, Adela; Bernabé Ortiz, Antonio; Miranda, J. Jaime; Beran, David (Wiley, 2023)
    AIMS: Describe the outcomes reported in research on health systems interventions for type 1 diabetes management in comparison to the outcomes proposed by a core outcome set (COS) for this condition, an essential list of ...
  • Precios, disponibilidad y asequibilidad de insulina en farmacias públicas y privadas en Perú 
    Tenorio Mucha, Janeth Marilyn; Lazo Porras, María de los Ángeles; Hidalgo Padilla, Liliana Milagros; Beran, David; Ewen, Margaret (Pan American Health Organization, 2019)
    Objective: Measure and compare the price, availability, and affordability of insulin and metformin in public and private pharmacies in six regions of Peru. Methods: Cross-sectional study using the World Health Organization/Health ...
  • The process of prioritization of non-communicable diseases in the global health policy arena 
    Heller, Olivia; Somerville, Claire; Suggs, L. Suzanne; Lachat, Sarah; Piper, Julianne; Aya Pastrana, Nathaly; Correia, Jorge C.; Miranda, J. Jaime; Beran, David (Oxford University Press, 2019)
    Although non-communicable diseases (NCDs) are the leading cause of morbidity and mortality worldwide, the global policy response has not been commensurate with their health, economic and social burden. This study examined ...
  • Rethinking research processes to strengthen co-production in low and middle income countries 
    Beran, David; Pesantes Villa, María Amalia; Berghusen, Maria Claudia; Hennig, Branwen J.; Jacobi, Johanna; Lazo Porras, María de los Ángeles; Llanque, Aymara; Placella, Enrichetta; Robledo-Abad, Carmenza; Bayona, Marta Tufet; Miranda, J. Jaime (BMJ Publishing Group, 2021)
    Co-production needs to become an integral part of the training and funding of researchers to ensure research meets everyone’s needs, argue David Beran and colleagues...
  • Social marketing interventions for the prevention and control of neglected tropical diseases: a systematic review 
    Aya Pastrana, Nathaly; Lazo Porras, María de los Ángeles; Miranda, J. Jaime; Beran, David; Suggs, L. Suzanne (Public Library of Science, 2020)
    BACKGROUND: Social marketing is an approach to behavior change that contributes to disease prevention and control. This study aimed to understand how social marketing interventions have addressed neglected tropical diseases ...
  • Technologies for Diabetes Self-Monitoring: A Scoping Review and Assessment Using the REASSURED Criteria 
    Zafra-Tanaka, Jessica Hanae; Beran, David; Vetter, Beatrice; Sampath, Rangarajan; Bernabé Ortiz, Antonio (SAGE Publications, 2021)
    BACKGROUND: Self-management is an important pillar for diabetes control and to achieve it, glucose self-monitoring devices are needed. Currently, there exist several different devices in the market and many others are ...
  • Teplizumab approval for type 1 diabetes in the USA. 
    Beran, David; Abidha, Carol; Adler, Amanda; de Beaufort, Carine; Lepeska, Molly; Levitt, Naomi; Pfiester, Elizabeth; Zafra Tanaka, Jessica Hanae; Gale, Edwin Am (Elsevier, 2023)
    The US Food and Drug Administration's (FDA) approval of teplizumab to delay the onset of type 1 diabetes could be seen as symbolic, because it came a century after the first use of insulin. Teplizumab, an anti-CD3 monoclonal ...

Buscar en el Repositorio

Listar

Panel de Control